ArticleBMC infectious diseases2026
Factors influencing influenza vaccine hesitancy among cancer patients: a multicenter cross-sectional study based on the Health Belief Model.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundCancer patients often become high-risk groups for influenza due to their immunosuppressed state, and the risk of severe illness after infection significantly increases. However, this group generally has influenza vaccine hesitancy, resulting in an unsatisfactory vaccination rate. This study aimed to investigate the influenza vaccination rate of cancer patients in China, systematically assessed the current situation of vaccine hesitancy, and explored its key influencing factors.
methodsFrom April to June 2025, a cross-sectional study design was adopted to conduct a questionnaire survey among cancer patients in six tertiary general hospitals in China. A self-designed structured questionnaire was used to investigate their influenza vaccination rate and the status of vaccine hesitancy. Chi-square test and t-test were used for univariate analysis, and binary logistic regression was employed to identify the independent predictors of vaccine hesitancy.
resultsThe questionnaires achieved a 91.6% (618/675) valid response rate. Vaccine hesitancy was reported by 491 participants (79.4%). Multivariate regression analysis indicated that higher perceived susceptibility (OR = 0.707, 95% CI: 0.548–0.857) and perceived benefits (OR = 0.635, 95% CI:0.562–0.717) and lower perceived barriers (OR = 0.673, 95% CI:0.585–0.774) provided protection against vaccine hesitation. The key risk factors included a duration of diagnosis of 1–4 years (OR = 2.964, 95% CI:1.449–6.063), reporting no history of influenza infection (OR = 2.336, 95% CI:1.118–4.882), and lack of physician recommendation (OR = 7.522, 95% CI:3.545–15.962).
conclusionsThis study highlights the prominent phenomenon of vaccine hesitancy among Chinese cancer patients. In the future, targeted intervention strategies need to be developed and translated into clinical practice to increase vaccination rates and improve long-term quality of life.
trial registrationChiCTR2500098953, registered in Mar, 17th, 2025. Prospective registered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.